CareGuidePro, a New Mobile App and Online Platform for Patients to Navigate Their Spinal Cord Stimulation Journey

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

CareGuidePro, is a mobile application and web portal that serves as a virtual guide for patients throughout their Medtronic spinal cord stimulation therapy journey.

The patient’s care team, including physicians and Medtronic, may also use the CareGuidePro platform to help manage and support the patient’s experience with spinal cord stimulation. Patients also have the ability to record their pain relief and other feedback directly into the app, providing detailed Patient Reported Outcomes (PROs) to ensure timely, essential information is recorded and accessible even outside of in-person office visits.

“Pain management is a complex and intensely personal experience for individual patients. Every patient is a singular case. The ability to monitor patients more closely, to receive data and feedback more quickly, means we can adjust and adapt therapies more efficiently and effectively when needed,” said Krishnan Chakravarthy, M.D., Ph.D., a San Diego-based interventional pain management physician and first physician to use the technology with patients. “This is an important step forward for the field of neuromodulation and patient care.”

“Knowledge is power, and digital health solutions like CareGuidePro give patients the tools they need to ask the right questions and make informed care decisions, which we know can lead to better long-term outcomes,” said Nandan Lad, M.D., Ph.D., professor of neurosurgery at Duke University and co-founder of Higgs Boson Health. “By providing patients with the right information at the right time, we also aim to reduce inefficiencies and free up care teams to focus on providing outstanding care.”

“CareGuidePro is Medtronic’s first patient-centric digital health platform created for spinal cord stimulation patients, intended as a seamless solution that will naturally integrate into the care provider’s workflow,” said Dave Anderson, president of the Neuromodulation business, which is part of the Neuroscience Portfolio at Medtronic. “We believe this digital health platform will facilitate a more informative and engaging patient experience that will translate into better physician-patient dialogue, potentially contributing to better therapy management.”

CareGuidePro features include:

  • Caregiver access for patients less familiar or able to manage the app, enabling easy access to essential information
  • Procedure-specific FAQs and task lists/reminders
  • Standardized and Custom Patient Reported Outcomes (PRO) surveys
  • Secure sharing of PROs to keep entire care team informed
  • Secure, encrypted two-way communication and file-sharing

Medtronic is currently enrolling patients for the app’s limited commercial release, with a full United States release expected in late summer. CareGuidePro is available on iOS® and Android™ devices.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles